MedElevator
Войти в исследования The Australian & New Zealand journal of obstetrics & gynaecology · 2020
Asherman syndrome: Audit of a single-operator cohort of 423 cases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vancaillie Thierry, Chan Karen, Liu Jinzhu, Deans Rebecca, Howard Elizabeth
Аннотация
BACKGROUND: The diagnosis of Asherman syndrome, or 'intra-uterine adhesions' is often overlooked when the symptoms of amenorrhea and hematometra are missing.
AIMS: This audit reviews the clinical data of a large cohort of patients treated by a single operator.
MATERIALS AND METHODS: From July 1998 till the end of December 2017, 423 patients with intra-uterine adhesions were treated by a single operator. Clinical information was obtained by review of the medical files and phone interviews.
RESULTS: Amenorrhea was recorded in 163/423 patients (38.5%), 225/423 (53.2%) patients did not have amenorrhea and for 35/423 (8.3%) patients the information was missing. A hematometra was documented in 19/423 (4.5%) patients. Pregnancy was achieved in 215/246 (87.4%). Patients with stage II disease did best with a pregnancy rate of 94.5% (P = 0.029).
CONCLUSION: Asherman syndrome should be considered in any woman with a history of miscarriage or postpartum curettage who then fails to conceive again.
AIMS: This audit reviews the clinical data of a large cohort of patients treated by a single operator.
MATERIALS AND METHODS: From July 1998 till the end of December 2017, 423 patients with intra-uterine adhesions were treated by a single operator. Clinical information was obtained by review of the medical files and phone interviews.
RESULTS: Amenorrhea was recorded in 163/423 patients (38.5%), 225/423 (53.2%) patients did not have amenorrhea and for 35/423 (8.3%) patients the information was missing. A hematometra was documented in 19/423 (4.5%) patients. Pregnancy was achieved in 215/246 (87.4%). Patients with stage II disease did best with a pregnancy rate of 94.5% (P = 0.029).
CONCLUSION: Asherman syndrome should be considered in any woman with a history of miscarriage or postpartum curettage who then fails to conceive again.